- Challenges in new drug development, including a long operating cycle and high risks.
- Changes in government regulations regarding new drug review.
Lumosa Therapeutics Co., Ltd.
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, Lumosa Therapeutics Co., Ltd. disclosed greenhouse gas emissions of 4.5K kg CO2/year (electricity saving) + 33000kg CO2/year (waste reduction). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
4.5K kg CO2/year (electricity saving) + 33000kg CO2/year (waste reduction)
2022
Waste
36 tons/year
2022
Energy Use
7.1K kwh/year (electricity saving)
2022
✅ Reported Environmental Achievements
- Implemented energy saving and waste reduction policies, resulting in an estimated 7,128kwh/year electricity saving and 36 tons/year waste reduction.
🎯 Climate & Sustainability Targets
🔭 Long-term
- Become a leader in innovative drug development in Taiwan and the most trusted biopharmaceutical company.